The age of appearance of first symptoms and clinical course of our patient was around 5 months, similar to the pattern reported in the first series of five patients with MYO5B mutations with progressive familial intrahepaticcholestasis-like phenotype with normal serum gamma-glutamyl transferase activity without intestinal disease.6 The gene discussed is MYO5B; the disease is intestinal disorder.